1-13 of 13
Authors: Mona Al-Gizawiy
Journal Article
CTNI-57. PRELIMINARY RESULTS OF A PHASE 1 TRIAL OF ORAL GALLIUM MALTOLATE IN RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v89, https://doi.org/10.1093/neuonc/noad179.0339
Published: 10 November 2023
Journal Article
ATRT-03. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE INHIBITS ATRT IN VIVO – IMAGING AND HISTOLOGICAL CHARACTERIZATION Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i1, https://doi.org/10.1093/neuonc/noad073.003
Published: 12 June 2023
Journal Article
EXTH-16. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE SUPPRESSES TREATMENT-RESISTANT GLIOBLASTOMA – IN VIVO VALIDATION Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii212, https://doi.org/10.1093/neuonc/noac209.815
Published: 14 November 2022
Journal Article
TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii233, https://doi.org/10.1093/neuonc/noaa215.975
Published: 09 November 2020
Journal Article
THER-12. NOVEL IRON-TARGETED THERAPY IS HIGHLY EFFECTIVE IN TREATMENT-RESISTANT HIGH-GRADE GLIOMA IN VIVO Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii116, https://doi.org/10.1093/neuonc/noz036.219
Published: 23 April 2019
Journal Article
HGG-05. GALLIUM MALTOLATE AS TREATMENT IN PEDIATRIC GLIOMA Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii87, https://doi.org/10.1093/neuonc/noz036.099
Published: 23 April 2019
Journal Article
EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi95, https://doi.org/10.1093/neuonc/noy148.396
Published: 05 November 2018
Journal Article
HGG-14. IRRADIATION OF PEDIATRIC GLIOBLASTOMA CELLS INDUCES DOWNREGULATION OF TUMOR SUPPRESSOR MICRORNA GENES AND UPREGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i91, https://doi.org/10.1093/neuonc/noy059.286
Published: 22 June 2018
Journal Article
NIMG-01ADVANCED MR PERFUSION AND DIFFUSION MEASURES DISTINGUISH BETWEEN GLIOMA SUBTYPES Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v153, https://doi.org/10.1093/neuonc/nov225.01
Published: 09 November 2015
Journal Article
GENO-02INTEGRATED ANALYSIS OF MOLECULAR SUBTYPES IN GLIOBLASTOMA MULTIFORME Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v91, https://doi.org/10.1093/neuonc/nov215.02
Published: 09 November 2015
Journal Article
ATPS-02CONTINUOUS ADMINISTRATION OF THE NOVEL IRON-MIMETIC GALLIUM MALTOLATE INHIBITS GLIOMA GROWTH IN VITRO AND IN VIVO Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v18, https://doi.org/10.1093/neuonc/nov204.02
Published: 09 November 2015
Journal Article
NI-03DSC-MRI MEASURES OF rCBV PREDICT TUMOR CHARACTERISTICS BEYOND STANDARD HISTOPATHOLOGY Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v138, https://doi.org/10.1093/neuonc/nou264.3
Published: 01 November 2014
Journal Article
NI-65DIFFERENTIATING RADIATION EFFECT AND NECROSIS FROM GLIOBLASTOMA WITH DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) MRI Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v152, https://doi.org/10.1093/neuonc/nou264.63
Published: 01 November 2014
